A prospective clinical study assessing the presence of exfoliated cancer cells and rectal washout including tumors in patients who receive neoadjuvant chemoradiotherapy for rectal cancer
ConclusionIn patients with rectal cancer, nCRT may decrease the number of exfoliated cancer cells in the rectum, and rectal washout including the tumor may be oncologically acceptable.
Source: Surgery Today - Category: Surgery Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Cytology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Papanicolaou (Pap) Smear | Rectal Cancers | Study | Surgery